Fortress Biotech, Inc.

FBIO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $95.0M $88.3M $98.2M $49.8M $99.5M $40.2M $23.2M $14.9M
Accounts Receivable $7.8M $1.8M $0 — — — — —
Inventory $171.0K $203.0K $0 — — — — —
Total Current Assets $183.2M $109.6M $99.9M $70.5M $100.0M $40.6M $23.4M $14.9M
Property, Plant & Equipment $7.1M $7.4M $309.0K $52.0K $447.0K $51.0K — $22.0K
Goodwill $18.6M $18.6M $0 — — — — —
Intangible Assets (Excl. Goodwill) $883.0K $17.4M $1.3M $0 — — — —
Total Assets $246.0M $170.7M $118.6M $89.3M $100.6M $41.0M $23.4M $14.9M
Liabilities
Accounts Payable $27.4M $24.3M $1.9M $366.0K $468.0K $1.0M $575.0K $476.0K
Total Current Liabilities $71.4M $56.6M $10.6M $4.1M $11.2M $5.1M $3.5M $1.6M
Long-Term Debt $67.5M $30.2M $24.0M $14.0M — — — —
Total Liabilities $125.4M $87.8M $34.3M $18.8M $19.3M $19.0M $4.2M $1.6M
Stockholders' Equity
Retained Earnings $-312.1M $-245.3M $-190.2M $-141.7M $-121.3M $-84.2M $-56.6M $-20.2M
Total Stockholders' Equity $52.6M $38.5M $56.8M $70.5M $81.3M $22.0M $19.1M $-15.9M
← Newer Page 2 of 2 Older →